Haisco Grants Airnexis Global Rights To HSK39004 In USD 1B+ Deal
12 Jan 2026 //
PR NEWSWIRE
AirNexis Funds $200M for Phase 2 Dual AN01 COPD Trial
09 Jan 2026 //
PHARMIWEB
Chiesi Group signed a License Agreement with Haisco Pharmaceutical
20 Nov 2023 //
PR NEWSWIRE

Market Place
Sourcing Support